≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other disorders of electrolyte and fluid balance, not elsewhere classified

EFO MESH Endpoint Browser PheWeb

E4_FLUIDELECTRONAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E87.8
  • Hospital discharge: ICD-9 — 276[8-9]
  • Cause of death: ICD-10 — E87.8
  • Cause of death: ICD-9 — 276[8-9]

2 out of 7 registries used, show all original rules.

315

4. Check minimum number of events

None

315

5. Include endpoints

None

315

6. Filter based on genotype QC (FinnGen only)

315

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E87
Name in latin
Aliae perturbationes aequilibrii electrolytici et humoralis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4640 3017 1556
Only index persons 2688 1786 902
Unadjusted period prevalence (%)
Whole population 0.07 0.09 0.04
Only index persons 0.06 0.07 0.03
Median age at first event (years)
Whole population 67.70 70.72 61.89
Only index persons 65.00 66.77 61.50

-FinnGen-

Key figures

All Female Male
Number of individuals 315 189 126
Unadjusted period prevalence (%) 0.06 0.06 0.06
Median age at first event (years) 61.26 59.22 64.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
279
Matched controls
2789
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E87.8
ICD-10 Finland
Other disorders of electrolyte and fluid balance, not elsewhere classified
+∞
205.5
171
*
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
+∞
115.9
103
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
140.4
70.8
73
7
E87.6
ICD-10 Finland
Hypokalaemia
75.1
35.0
39
6
A12BA01
ATC
potassium chloride; oral
7.6
21.7
53
83
C03DA01
ATC
spironolactone; oral
5.5
21.7
71
164
E86
ICD-10 Finland
Volume depletion
95.8
16.8
18
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
8.6
15.6
34
44
205
Kela drug reimbursment
Chronic hypertension
2.9
14.8
125
611
R53
ICD-10 Finland
Malaise and fatigue
3.1
13.9
89
362
C03CA01
ATC
furosemide; systemic
2.7
13.5
128
664
E87.5
ICD-10 Finland
Hyperkalaemia
30.0
13.1
17
6
R11
ICD-10 Finland
Nausea and vomiting
4.5
11.8
43
109
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
10.8
97
476
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.9
10.6
45
131
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
+∞
10.5
10
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
6.2
10.3
27
47
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.1
10.2
62
238
N17.9
ICD-10 Finland
Acute renal failure, unspecified
7.0
10.0
24
37
N05BA01
ATC
diazepam; systemic, rectal
3.2
9.6
54
196
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.7
9.3
73
326
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
9.2
60
241
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
9.1
54
202
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
9.0
64
269
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
7.0
8.8
21
32
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.5
8.8
22
36
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
8.7
94
496
H02AB09
ATC
hydrocortisone; systemic
13.3
8.5
14
11
F05.9
ICD-10 Finland
Delirium, unspecified
13.3
8.5
14
11
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.5
8.4
29
70
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
+∞
8.4
8
*
AA1AD
NOMESCO Finland
CT of head and brain
2.4
8.3
81
406
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
12.2
8.2
14
12
N03AX16
ATC
pregabalin; oral
2.4
8.1
74
359
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.6
8.0
27
64
C02EA02
ATC
NA
4.1
8.0
30
79
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.8
7.9
15
16
N06AX11
ATC
mirtazapine; oral
2.2
7.7
94
522
N19
ICD-10 Finland
Unspecified kidney failure
6.1
7.7
20
35
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.2
7.6
15
17
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
7.5
42
151
E87.3
ICD-10 Finland
Alkalosis
+∞
7.3
7
*
E87.2
ICD-10 Finland
Acidosis
+∞
7.3
7
*
K59.1
ICD-10 Finland
Functional diarrhoea
4.6
7.2
24
56
C07AB07
ATC
bisoprolol; oral
2.0
7.2
142
951
F10.24
ICD-10 Finland
Alcohol depence active use
20.6
7.2
10
5
C08CA01
ATC
amlodipine; oral
2.0
7.0
112
689
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
6.4
6.9
17
28
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
6.8
99
584
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
6.8
170
1239
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
6.8
40
150
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
17.2
6.8
10
6
F50.9
ICD-10 Finland
Eating disorder, unspecified
17.2
6.8
10
6
N05AH04
ATC
quetiapine; oral
2.7
6.7
48
202
A10BH01
ATC
sitagliptin; oral
3.1
6.6
35
122
SPAT1211
SPAT
Application of soft bandage
3.1
6.6
35
122
A06AD11
ATC
lactulose; oral
2.4
6.6
60
288
N05BA04
ATC
oxazepam; oral
2.2
6.5
79
431
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.5
126
831
N03AX14
ATC
levetiracetam; systemic
6.8
6.4
15
23
124
Kela drug reimbursment
Inborn metabolic disorders
+∞
6.3
6
*
E83.51
ICD-10 Finland
Hypocalcemia
+∞
6.3
6
*
E87
ICD-10 Finland
Other disorders of fluid, electrolyte and acid-base balance
+∞
6.3
6
*
2768X
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[NESTE-, ELEKTROLYYTTI- JA HAPPOEMÄSTASAP MUUT HÄIR]
+∞
6.3
6
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
6.2
36
133
R42
ICD-10 Finland
Dizziness and giddiness
2.1
6.2
74
402
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
6.1
53
249
N03AG01
ATC
valproic acid; systemic, rectal
4.1
6.0
22
57

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003181) Sodium [Moles/volume] in Urine
62
21
36.51
95.83
2.4
1.1
mmol/l
62.9
55.8
0.37
53
16
(3008295) Osmolality of Serum or Plasma
36
21
19.23
44.33
1.5
1.0
mosm/kgh2o
267.2
284.0
3.38
29
16
(3002032) Base excess in Venous blood by calculation
83
193
5.48
35.29
7.6
3.0
mmol/l
3.1
2.3
0.77
72
155
(3012544) pH of Venous blood
83
197
5.36
34.41
7.0
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
64
161
4.73
24.26
10.0
6.2
—
—
—
0
0
(3026782) Osmolality of Urine
116
471
3.32
21.90
3.0
2.7
mosm/kgh2o
430.4
533.0
7.62
101
388
(3024354) Oxygen [Partial pressure] in Venous blood
62
168
4.35
21.25
7.5
2.4
kpa
4.1
4.3
0.49
62
161
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
60
170
4.12
19.29
2.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
51
132
4.42
18.44
4.5
3.4
mmol/l
3.2
1.9
0.75
34
101
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
126
585
2.92
18.28
2.8
2.2
mg/l
3.0
3.3
1.06
116
485
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
67
5.75
17.94
1.7
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
51
137
4.25
17.54
4.8
3.4
ph
7.4
7.4
—
9
16
(3020779) Urea [Moles/volume] in Serum or Plasma
56
165
3.91
16.96
7.1
4.4
mmol/l
11.1
10.5
0.20
56
153
(3023368) Bacteria identified in Blood by Culture
130
654
2.68
15.70
5.8
4.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
29
54
5.81
15.25
4.2
3.1
kpa
8.4
8.0
0.73
29
48
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
192
1183
2.60
15.02
13.3
5.6
mmol/l
1.2
1.2
1.70
169
983
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
76
302
3.00
14.20
2.6
1.9
%
21.6
21.7
0.01
68
255
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
133
712
2.50
13.74
4.2
2.3
u/l
56.5
55.7
0.08
127
648
(3021901) Oxygen saturation in Capillary blood
24
41
6.25
13.74
3.5
2.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
83
357
2.80
13.34
2.5
1.9
umol/l
11.8
12.8
0.66
76
325
(3013826) Glucose [Moles/volume] in Serum or Plasma
205
1356
2.47
12.98
10.4
4.3
mmol/l
7.1
6.7
1.73
199
1266
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
49
165
3.33
12.00
3.4
2.5
ng/l
96.9
83.4
0.38
43
140
(3002030) Lymphocytes/100 leukocytes in Blood
173
1088
2.31
11.93
6.9
5.2
%
25.2
27.4
1.81
166
995
(3019069) Monocytes/100 leukocytes in Blood
170
1064
2.30
11.82
6.9
5.2
%
8.7
8.8
0.10
164
984
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
173
1091
2.30
11.81
14.2
4.9
mmol/l
1.2
1.2
2.38
165
973
(3018010) Neutrophils/100 leukocytes in Blood
171
1078
2.28
11.62
6.5
4.9
%
59.4
57.3
1.32
163
992
(3019198) Lymphocytes [#/volume] in Blood
181
1172
2.28
11.48
7.0
4.9
e9/l
1.8
1.7
0.06
160
1031
(3001604) Monocytes [#/volume] in Blood
177
1137
2.27
11.43
7.0
4.8
e9/l
0.6
0.6
0.83
160
985
(3006504) Eosinophils/100 leukocytes in Blood
168
1061
2.25
11.25
6.7
4.9
%
2.8
2.8
0.14
162
974
(3013115) Eosinophils [#/volume] in Blood
181
1182
2.25
11.12
7.2
5.0
e9/l
0.2
0.2
0.53
164
1043
(3032080) INR in Blood by Coagulation assay
157
968
2.24
11.11
11.3
9.6
inr
1.3
1.3
0.31
50
288
(3006315) Basophils [#/volume] in Blood
177
1147
2.24
11.06
7.0
4.9
e9/l
0.0
0.0
0.25
159
990
(3003396) Base excess in Arterial blood by calculation
64
263
2.80
11.06
11.5
7.4
mmol/l
2.4
1.3
0.81
53
202
(3022096) Basophils/100 leukocytes in Blood
164
1031
2.23
11.04
6.8
5.0
%
0.7
0.6
0.55
158
945
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
211
2.95
10.77
2.3
1.8
%
1.8
1.4
2.74
48
182
(3024561) Albumin [Mass/volume] in Serum or Plasma
160
1017
2.17
10.24
7.7
3.9
g/l
33.5
35.0
2.60
150
934
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
81
391
2.44
10.03
2.2
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
149
929
2.15
9.94
3.4
2.4
ug/l
170.7
127.8
0.96
144
819
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
148
923
2.14
9.84
3.0
2.1
nmol/l
76.6
79.1
0.47
135
794
(3023520) Reticulocytes [#/volume] in Blood
48
182
2.93
9.56
2.1
2.8
e9/l
72.7
66.3
0.62
34
151
(3026008) Bacteria identified in Urine by Culture
130
779
2.14
9.51
4.1
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
145
927
2.05
8.74
6.2
3.6
ng/l
28.0
38.7
1.12
118
673
(42870588) Differential panel, method unspecified - Blood
124
749
2.08
8.73
6.7
4.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
36
5.24
8.72
7.9
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
120
719
2.08
8.61
6.4
3.1
ph
7.4
7.4
0.06
28
150
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
176
1220
2.00
8.32
8.8
5.6
umol/l
10.7
11.5
0.48
171
1143
(3019060) Gas panel - Arterial blood
43
166
2.84
8.26
10.2
6.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
11
9.36
8.13
1.3
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
46
187
2.71
8.02
1.6
2.0
g/l
65.6
67.2
0.68
46
169
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
33
112
3.17
7.92
10.8
5.1
mmol/l
25.0
25.0
0.01
33
112
(3021960) Folate [Moles/volume] in Serum or Plasma
102
595
2.06
7.72
1.8
1.5
nmol/l
20.9
21.3
0.11
93
484
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
48
204
2.60
7.66
2.5
2.4
g/l
0.2
0.2
0.25
41
188
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
133
856
1.96
7.60
4.6
2.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
45
4.43
7.58
3.4
2.1
%
16.2
15.4
0.33
13
17
(3013650) Neutrophils [#/volume] in Blood by Automated count
184
1322
1.94
7.55
12.3
8.3
e9/l
4.1
4.0
0.27
168
1165
(3025941) Bacteria identified in Stool by Culture
36
135
2.88
7.28
1.8
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
102
3.15
7.18
5.3
3.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
66
3.68
7.13
1.4
1.3
ug/g
227.8
297.1
0.99
16
41
(3017181) Myelocytes/100 leukocytes in Blood
45
192
2.57
7.11
4.3
3.7
%
1.7
1.0
0.49
19
58
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
30
105
3.05
6.84
11.2
2.0
%
0.6
0.7
0.15
30
100
(3009508) Creatinine [Moles/volume] in Urine
109
677
1.93
6.76
3.5
2.8
mmol/l
5.8
7.2
2.51
93
554
(3012516) Albumin [Mass/volume] in Urine
105
648
1.93
6.62
3.4
2.9
mg/l
966.7
245.0
0.57
74
398
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
83
472
2.03
6.61
1.4
1.2
u/ml
0.7
1.4
0.82
26
123
(3037522) Nuclear Ab [Titer] in Serum
54
262
2.28
6.43
1.3
1.4
titre
424.0
575.1
—
10
53
(3018095) Leukocytes [#/volume] in Urine
126
836
1.85
6.29
5.1
3.4
e6/l
94.8
169.8
0.39
106
591
(1616796) Gas panel - Central venous blood
17
43
4.12
6.25
4.9
2.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
142
983
1.81
6.13
2.2
2.0
pmol/l
99.6
95.8
0.39
85
479
(3020682) Albumin/Creatinine [Ratio] in Urine
108
690
1.86
6.03
4.1
3.5
mg/mmol
21.2
6.3
1.15
69
419
(3007164) IgA [Mass/volume] in Serum or Plasma
72
406
2.00
5.81
1.8
1.3
g/l
2.5
2.5
0.07
47
235
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
224
1795
1.86
5.77
11.8
6.8
u/l
85.4
80.4
0.63
213
1655
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
28
104
2.86
5.77
5.1
8.8
%
1.8
1.6
0.27
28
97
(3021440) Promyelocytes/100 leukocytes in Blood
41
185
2.40
5.75
4.1
3.8
%
0.3
0.1
0.59
15
52
(3004588) Protein electrophoresis panel - Serum or Plasma
37
161
2.47
5.61
1.6
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
35
149
2.52
5.55
2.5
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
39
175
2.40
5.53
3.9
3.7
%
1.0
0.4
0.61
11
37
(3002582) Erythrocytes [#/volume] in Urine
110
726
1.79
5.43
4.3
2.9
e6/l
15.0
173.8
1.08
99
553
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
113
755
1.77
5.33
3.8
2.9
ng/l
3485.3
1442.3
1.30
104
631
(36304419) Bacteria [Presence] in Urine
98
628
1.81
5.32
4.3
2.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
240
2.18
5.30
3.1
2.4
umol/l
7.7
8.3
0.09
36
206
(3030467) Casts [#/volume] in Urine by Automated count
101
660
1.78
5.11
4.2
2.8
e6/l
0.4
0.4
0.12
86
483
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
55
3.41
5.11
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
529
1.83
5.04
2.0
1.8
nmol/l
1313.7
1188.9
0.51
73
385
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
46
3.61
4.96
2.1
2.8
ug/min
141.1
118.3
0.09
11
26
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
51
268
2.08
4.95
2.4
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
200
1593
1.70
4.80
7.9
4.5
e6/l
302.7
3920.1
—
6
28
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
23
85
2.84
4.79
5.5
3.7
mmol/l
26.7
24.7
0.76
23
85
(40760888) Immunoglobulin light chains.free panel - Serum
15
43
3.61
4.67
1.3
3.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
90
583
1.76
4.63
3.7
2.5
umol/l
362.0
6258.1
2.59
81
491
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
81
2.84
4.62
1.6
1.5
g/l
3.9
3.6
0.34
17
59
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
81
2.84
4.62
1.6
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
81
2.84
4.62
1.6
1.5
g/l
8.2
7.5
0.85
17
61
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
11
8.38
4.59
1.3
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
21
4.89
4.56
1.3
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
137
999
1.66
4.54
14.3
9.1
e9/l
0.0
0.0
0.65
121
822
(3035350) Ketones [Presence] in Urine by Test strip
155
1167
1.65
4.53
6.6
3.7
estimate
0.0
0.0
0.00
37
232
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
538
1.77
4.48
2.0
1.7
pmol/l
466.8
451.9
0.17
75
427
(3021601) Nitrite [Presence] in Urine by Test strip
155
1172
1.63
4.42
8.1
5.1
estimate
0.0
0.0
0.00
36
225
(40768797) Stomach Pathology biopsy report
56
318
1.93
4.37
1.4
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
266
2.00
4.35
2.4
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
22
4.66
4.33
1.2
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
31
141
2.33
4.28
1.8
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
29
130
2.36
4.14
18.1
6.7
%
92.1
93.9
0.40
29
130
(3048689) Calprotectin [Mass/mass] in Stool
49
271
1.96
4.13
2.7
2.3
ug/g
154.9
121.7
0.48
42
213
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
74
467
1.76
4.12
2.0
1.6
mg/l
1.2
1.1
0.16
60
363
(3042936) Bacteria identified in Isolate by Culture
59
348
1.86
4.10
2.3
2.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
13
37
3.62
4.09
3.1
1.5
mmol/l
1.6
1.6
0.00
13
37
(3022217) INR in Platelet poor plasma by Coagulation assay
54
310
1.90
4.08
20.0
25.6
inr
1.4
1.4
0.00
11
48
(3044640) Blood type and Crossmatch panel - Blood
103
714
1.66
4.07
3.8
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
53
3.13
4.02
3.3
2.4
u/ml
0.5
0.3
—
10
33
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
33
3.74
3.96
2.1
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
115
825
1.62
3.95
3.6
3.1
mmol/l
2.3
2.4
0.20
101
707
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
195
2.08
3.93
1.7
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
154
1187
1.58
3.90
6.7
3.8
estimate
0.0
0.0
0.00
33
226
(40758558) Short blood count panel - Blood
83
552
1.68
3.81
8.3
6.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
12
34
3.63
3.80
4.2
3.1
%
1.1
1.0
—
7
27
(40760892) CBC W Ordered Manual Differential panel - Blood
76
497
1.70
3.71
5.3
4.6
—
—
—
0
0
(3020891) Body temperature
23
98
2.45
3.67
22.3
3.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
46
260
1.90
3.64
1.7
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
34
173
2.08
3.60
4.1
3.9
%
0.0
0.2
—
10
43
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
13
6.28
3.52
1.0
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
382
1.74
3.46
3.6
2.6
e6/l
0.6
1.2
1.98
42
215
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
221
1.93
3.38
1.6
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
32
3.53
3.36
1.1
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
19
4.84
3.26
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
19
4.84
3.26
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
47
278
1.81
3.23
3.0
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
99
2.31
3.14
1.8
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
20
4.60
3.13
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
175
1432
1.50
3.12
4.9
2.9
u/l
82.5
48.4
2.12
164
1315
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
106
2.26
3.11
12.1
11.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
87
2.39
3.07
4.4
3.0
g/l
0.3
0.2
0.62
14
30
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
29
3.53
3.07
1.1
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
8
7.62
3.06
1.3
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
69
2.55
3.01
1.9
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
155
1245
1.48
2.98
3.3
2.8
—
—
—
0
0
(3013512) EKG study
100
734
1.53
2.97
5.4
3.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
9
6.77
2.88
7.8
12.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
9
6.77
2.88
3.0
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
65
435
1.62
2.87
5.9
3.5
ng/l
111.2
195.8
0.52
55
348
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
124
2.10
2.85
1.5
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
18
4.53
2.81
1.4
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
31
3.30
2.79
1.1
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
42
2.93
2.78
1.4
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
42
2.93
2.78
1.4
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
42
2.93
2.78
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
42
2.93
2.78
1.7
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
10
6.09
2.71
1.2
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
77
545
1.55
2.67
3.7
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
156
1.95
2.67
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
75
530
1.54
2.62
6.6
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
143
1.97
2.60
1.9
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
20
4.08
2.58
1.4
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
192
1638
1.44
2.53
7.5
4.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
39
2.89
2.50
1.4
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
160
0.30
2.49
2.0
1.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
51
2.62
2.47
5.5
2.6
mmol/l
2.6
2.6
—
8
32
(3013290) Carbon dioxide [Partial pressure] in Blood
13
51
2.62
2.47
5.5
2.6
kpa
4.9
4.9
0.01
13
51
(3027315) Oxygen [Partial pressure] in Blood
13
51
2.62
2.47
5.5
2.6
kpa
8.6
8.1
0.41
13
51
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
34
3.00
2.43
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
131
1051
1.42
2.39
6.1
4.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
8
6.33
2.38
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
8
6.33
2.38
21.2
1.1
%
7.5
11.9
—
5
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
8
6.33
2.38
1.4
1.1
—
—
—
0
0
(4281824)
8
22
3.70
2.38
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
22
3.70
2.38
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
17
4.19
2.37
1.3
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
119
940
1.43
2.36
7.3
4.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
15
65
2.37
2.35
1.5
1.5
g/l
0.0
1.6
1.85
15
55
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
257
1.68
2.33
4.7
3.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
14
59
2.44
2.32
1.6
1.5
g/l
0.0
0.0
0.00
14
52
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
35
2.92
2.32
1.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
35
2.92
2.32
4.3
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
35
2.92
2.32
2.4
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
35
2.92
2.32
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
47
2.61
2.30
1.2
1.7
—
—
—
0
0
(44790047)
8
23
3.54
2.28
2.6
1.4
—
—
—
0
0
(44790048)
8
23
3.54
2.28
2.6
1.4
—
—
—
0
0
(44806118)
8
23
3.54
2.28
2.6
1.4
—
—
—
0
0
(44790049)
8
23
3.54
2.28
2.6
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
15
66
2.34
2.28
1.7
1.5
g/l
38.4
37.3
0.26
15
56
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
9
5.62
2.22
3.0
2.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
9
5.62
2.22
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.62
2.22
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
9
5.62
2.22
3.0
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
48
2.56
2.21
1.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
19
3.74
2.16
2.3
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
19
3.74
2.16
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
14
4.35
2.16
2.3
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
203
1776
1.40
2.16
5.4
3.9
pmol/l
15.6
15.0
2.15
187
1567
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
55
2.42
2.15
2.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
86
650
1.44
2.14
5.9
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
43
2.61
2.12
1.5
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
13
56
2.38
2.07
7.7
13.0
mmol/l
13.7
10.8
1.26
13
50
(3018572) Chloride [Moles/volume] in Blood
13
56
2.38
2.07
7.7
13.1
mmol/l
97.8
105.3
2.10
13
50
(3029937) Albumin [Presence] in Urine by Test strip
88
672
1.43
2.07
8.5
4.0
estimate
0.0
0.0
0.00
35
223
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
350
1.55
2.02
3.8
2.7
e6/l
1.7
2.1
0.22
31
184
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
32
2.86
2.01
1.1
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
33
2.78
1.94
3.1
1.2
%
89.9
89.1
—
9
33
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
13
58
2.29
1.93
1.6
1.6
g/l
0.0
0.0
0.00
13
52
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
52
2.36
1.90
2.8
1.6
—
—
—
0
0
(3019225) pH of Specimen
37
239
1.62
1.89
7.5
3.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
93
1.99
1.89
1.7
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
79
2.08
1.89
2.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
34
2.69
1.88
1.3
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
13
59
2.26
1.87
1.6
1.5
g/l
0.0
0.0
0.00
13
52
(3045142) Bone marrow Pathology biopsy report
6
17
3.58
1.84
2.0
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
17
3.58
1.84
4.8
2.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
80
2.05
1.83
2.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
35
2.62
1.81
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
35
2.62
1.81
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
35
2.62
1.81
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
35
2.62
1.81
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
29
2.80
1.80
1.1
1.2
nmol/l
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
29
2.80
1.80
1.4
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
29
2.80
1.80
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
60
2.22
1.80
1.8
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
47
2.39
1.79
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
81
2.03
1.78
2.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
41
2.49
1.77
2.7
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
18
3.38
1.75
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
36
2.54
1.75
1.4
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
14
3.61
1.62
1.0
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
14
3.61
1.62
1.4
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
32
2.54
1.61
15.1
1.3
%
51.1
61.0
—
8
32
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
63
474
1.41
1.59
3.7
3.0
mmol/l
2.5
2.5
0.16
53
418
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
2.5
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
2.5
2.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
20
3.04
1.59
1.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
2.5
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
15
3.37
1.53
2.0
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
15
3.37
1.53
1.4
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
27
2.63
1.52
2.6
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
27
2.63
1.52
2.6
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
79
1.94
1.52
1.8
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
72
1.99
1.51
3.0
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
235
2160
1.35
1.50
6.2
4.6
mu/l
1.8
2.0
0.90
223
1916
(3022145) Colonoscopy Study observation
37
254
1.52
1.49
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
102
1.81
1.48
1.2
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
28
2.53
1.46
1.7
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
16
3.16
1.44
1.8
5.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
22
2.76
1.44
1.0
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
196
1763
1.30
1.42
6.5
4.0
mm/h
17.1
13.0
2.85
188
1606
(4010399)
27
175
1.59
1.40
1.6
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
41
2.23
1.38
1.0
1.3
—
17.0
—
0
5
(3044927) Protein electrophoresis panel - Urine
6
23
2.64
1.37
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
211
1.52
1.31
8.3
3.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
24
2.53
1.31
1.0
2.5
nmol/l
3.8
3.6
—
6
24
(3019150) Specific gravity of Urine by Refractometry
67
527
1.34
1.30
7.5
4.0
kg/l
1.0
1.0
0.26
15
69
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
2.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
35
2.32
1.27
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
182
1636
1.27
1.26
4.8
3.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
19
2.66
1.22
3.4
4.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
19
2.66
1.22
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
35
249
1.46
1.21
2.2
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
26
2.33
1.19
3.8
3.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
30
2.36
1.13
3.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
248
2332
1.30
1.10
32.3
13.7
mg/l
26.1
24.3
0.34
228
1832
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
378
1.35
1.09
1.3
1.3
u/ml
36.9
10.6
0.54
15
140
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
33
2.15
1.06
1.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
180
1.48
1.04
2.9
2.9
ml/min/173m2
64.3
60.7
0.21
11
64
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
22
2.29
1.04
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
4.1
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
131
1.56
1.02
1.1
1.4
—
39.3
—
0
8
(40761536) Microorganisms panel - Urine sediment
29
207
1.44
1.01
8.3
3.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
257
2438
1.29
0.99
43.2
15.8
mmol/l
137.0
139.8
17.19
251
2363
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
124
1.57
0.99
2.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
1.2
—
0
14
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
30
0.00
0.98
0.0
1.1
—
5.1
—
0
14
(21494755) Public health laboratory ask at order entry panel
10
172
0.57
0.96
1.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
49
386
1.32
0.96
1.3
1.3
iu/ml
21.1
40.7
1.11
16
123
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
37
1.91
0.94
4.6
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
37
1.91
0.94
1.1
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
257
2445
1.28
0.92
42.1
15.9
mmol/l
4.0
4.0
0.60
251
2366
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
29
2.09
0.90
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
62
742
0.80
0.86
3.1
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
107
938
1.21
0.86
2.5
2.1
—
—
—
0
0
(4035726)
27
197
1.41
0.85
1.8
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.85
4.2
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
73
1.67
0.83
4.3
5.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
32
1.89
0.82
3.7
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
98
1.56
0.80
2.7
2.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
59
1.72
0.76
1.0
1.1
—
15.5
—
0
7
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
25
2.02
0.73
2.6
3.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
25
2.02
0.73
11.0
2.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
69
1.62
0.69
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
27
1.87
0.68
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
27
1.87
0.68
1.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
145
1.41
0.67
1.9
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
78
1.56
0.66
2.7
2.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
44
1.60
0.65
4.9
3.2
%
65.1
57.1
—
7
44
(3019832) Treponema pallidum Ab [Presence] in Serum
16
112
1.45
0.65
2.0
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
216
2259
0.86
0.57
4.5
4.2
mmol/l
1.5
1.5
0.49
201
2031
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
2.0
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
36
1.68
0.57
2.5
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
36
1.68
0.57
1.2
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
224
2335
0.86
0.56
5.2
4.8
mmol/l
2.5
2.7
3.19
212
2093
(40768806) Pleura Pathology biopsy report
6
39
1.55
0.53
1.2
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
154
1.32
0.50
2.2
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
46
1.53
0.48
1.1
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
165
1.29
0.46
4.7
3.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
49
1.44
0.46
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
50
1.41
0.45
2.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
50
1.41
0.45
2.0
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
391
0.83
0.44
2.9
3.1
ug/l
0.7
0.7
0.23
26
255
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
270
1.21
0.40
2.7
4.1
ug/l
130.3
51.7
0.26
27
228
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
0.2
—
0
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
71
1.42
0.39
1.8
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
66
1.37
0.38
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
67
1.35
0.38
2.0
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
72
1.40
0.37
2.7
3.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
37
1.36
0.37
1.0
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
41
1.47
0.36
4.7
2.8
e9/l
4.4
4.4
—
6
41
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
318
0.83
0.35
21.5
6.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
45
1.34
0.34
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
50
557
0.88
0.33
1.4
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
221
2276
0.90
0.33
4.5
4.3
mmol/l
4.4
4.7
2.39
208
2063
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
55
1.28
0.30
1.9
2.0
mg/l
14.0
12.3
—
7
50
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
139
1.24
0.29
7.5
3.3
u/ml
121.3
51.7
0.59
17
133
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
321
0.86
0.28
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
63
1.28
0.28
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
213
0.84
0.26
1.9
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
77
1.17
0.24
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
50
542
0.91
0.22
5.8
4.4
%
22.4
21.8
0.10
28
270
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
43
1.17
0.21
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
50
1.20
0.20
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
221
2164
1.07
0.19
7.5
5.6
mmol/mol
41.8
40.0
1.74
214
1973
(3002256) Pathology report gross observation
27
300
0.89
0.19
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
132
0.83
0.18
1.5
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
61
1.15
0.17
1.7
1.5
pmol/l
275.9
261.2
—
7
61
(40761511) CBC panel - Blood by Automated count
247
2432
1.07
0.17
27.9
13.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
677
0.93
0.17
5.3
4.8
ug/l
4.6
4.4
0.03
58
593
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
71
1.13
0.16
2.0
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
11
130
0.84
0.16
1.0
1.2
iu/ml
189.3
147.4
—
5
54
(3001019) Free T4 and TSH panel - Serum or Plasma
6
76
0.79
0.16
3.5
1.4
—
—
—
0
0
(4034850)
9
78
1.16
0.15
20.4
7.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
113
1.16
0.13
1.3
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
63
603
1.06
0.11
1.7
1.6
mmol/l
1.5
1.3
0.75
54
486
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
251
2487
1.05
0.09
17.0
9.9
u/l
25.1
24.0
0.55
243
2377
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
227
2294
0.96
0.08
5.3
4.6
mmol/l
6.4
6.0
2.63
203
2045
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
2.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
65
0.77
0.08
1.4
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
222
2198
1.03
0.07
29.5
12.9
ml/min/173m2
75.1
76.5
0.36
194
1804
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
217
2188
0.97
0.05
4.0
3.8
mmol/l
1.4
1.2
1.30
202
1958
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
317
1.05
0.05
1.7
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
257
2584
0.97
0.04
44.7
20.1
e9/l
6.9
6.6
2.64
250
2499
(3026361) Erythrocytes [#/volume] in Blood
257
2584
0.97
0.04
44.7
20.1
e12/l
4.2
4.4
7.02
250
2498
(3007461) Platelets [#/volume] in Blood
257
2583
0.97
0.04
44.6
20.1
e9/l
260.0
246.5
2.06
251
2509
(3000330) Specific gravity of Urine by Test strip
13
122
1.07
0.02
4.9
4.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
205
2060
0.99
0.02
29.6
14.4
%
37.3
39.2
1.67
125
1388
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
32
322
0.99
0.00
4.1
4.2
%
36.7
33.2
1.35
27
204
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
147
1.02
0.00
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
20
196
1.02
0.00
1.8
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
93
0.97
0.00
2.9
1.9
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
10.7
—
1690.0
—
0
6
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
905.3
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
59
1.02
0.00
1.2
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
59
0.85
0.00
1.2
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
18.5
—
0
7
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FLUIDELECTRONAS and mortality.

Females

Parameter HR [95% CI] p-value
E4_FLUIDELECTRONAS 2.068 [1.65, 2.59] < 0.001
Birth year 0.997 [0.99, 1.01] 0.524

During the follow-up period (1.1.1998 — 31.12.2019), 438 out of 950 females with E4_FLUIDELECTRONAS died.

Males

Parameter HR [95% CI] p-value
E4_FLUIDELECTRONAS 5.006 [2.97, 8.43] < 0.001
Birth year 0.987 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 272 out of 534 males with E4_FLUIDELECTRONAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_FLUIDELECTRONAS.

N-year risk Females Males
1 0.155% 0.87%
5 1.318% 5.3%
10 3.19% 13.38%
15 6.384% 24.389%
20 10.98% 38.141%

Relationships between endpoints

↥

Index endpoint: E4_FLUIDELECTRONAS – Other disorders of electrolyte and fluid balance, not elsewhere classified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data